MBX Biosciences, Inc. (MBX) stock forecast — our track record
4 completed MBX stock predictions — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our MBX forecasts have done
Lyra published 4 MBX stock forecasts starting December 5, 2025. Each prediction was published before the outcome was known, and each one was later closed and scored. All 4 calls used the short term (0 to 3 months) horizon. The last closed window ended April 12, 2026, so this summary covered only completed calls for MBX Biosciences, Inc.
Overall, 4 targets were reached, with no misses. The average success score was 93.8%. The short term calls also averaged 93.8%, because every forecast used that horizon. Peak gains across the closed calls averaged 40.3%. The results were concentrated in a small number of short term predictions, so the record was clean but limited in size.
The best call was published on December 5, 2025. It predicted 38% growth, and the stock rose as much as 44.9%. The target was reached in 40 days, and the call scored 100%. The lowest-scored call was published on December 6, 2025. It predicted 42% growth, and the stock rose as much as 40.4%. That call scored 75%. The track record was strong across these 4 closed MBX calls, with every target reached and no misses.
Written from the closed signals below; refreshed when new signals close.
Closed MBX signals
| Closed | Timeframe | Predicted | Peak result | Outcome | Days to target | |
|---|---|---|---|---|---|---|
| April 12, 2026 | ||||||
| March 9, 2026 | ||||||
| March 6, 2026 | ||||||
| March 5, 2026 |
Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.
Share this receipt
The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way MBX was. No deleted misses, no cherry-picking.